Header

UZH-Logo

Maintenance Infos

Is laser trabeculoplasty the new star in glaucoma treatment?


Töteberg-Harms, Marc; Meier-Gibbons, Frances (2021). Is laser trabeculoplasty the new star in glaucoma treatment? Current Opinion in Ophthalmology, 32(2):141-147.

Abstract

PURPOSE OF REVIEW
For decades, laser trabeculoplasty has been a well-proven therapeutic option in glaucoma management, and more recently, it has only gained in popularity. One reason for such popularity is that selective laser trabeculoplasty (SLT) is a therapy independent of patient adherence, which is typically low among glaucoma patients. Consequently, the number of studies on SLT has multiplied throughout the past years. This review provides an overview of studies on SLT from the last 12 months.

RECENT FINDINGS
The studies on treatment outcome show a wide range of success rates of SLT reaching between 18 and 88%; however, study designs differ and many studies are not directly comparable. The prospective laser trabeculoplasty for open-angle glaucoma and ocular hypertension (LiGHT) trial has demonstrated good efficacy of SLT - 75% of the eyes achieved their target pressure without drops and 58% after a single SLT.

SUMMARY
SLT has proven to be effective in lowering IOP with satisfactory success rates even after single SLT. SLT is repeatable independent of patient's adherence.

Abstract

PURPOSE OF REVIEW
For decades, laser trabeculoplasty has been a well-proven therapeutic option in glaucoma management, and more recently, it has only gained in popularity. One reason for such popularity is that selective laser trabeculoplasty (SLT) is a therapy independent of patient adherence, which is typically low among glaucoma patients. Consequently, the number of studies on SLT has multiplied throughout the past years. This review provides an overview of studies on SLT from the last 12 months.

RECENT FINDINGS
The studies on treatment outcome show a wide range of success rates of SLT reaching between 18 and 88%; however, study designs differ and many studies are not directly comparable. The prospective laser trabeculoplasty for open-angle glaucoma and ocular hypertension (LiGHT) trial has demonstrated good efficacy of SLT - 75% of the eyes achieved their target pressure without drops and 58% after a single SLT.

SUMMARY
SLT has proven to be effective in lowering IOP with satisfactory success rates even after single SLT. SLT is repeatable independent of patient's adherence.

Statistics

Citations

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Ophthalmology Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:18 January 2021
Deposited On:28 Jan 2021 10:59
Last Modified:28 Feb 2021 08:54
Publisher:Lippincott Williams & Wilkins
ISSN:1040-8738
OA Status:Closed
Publisher DOI:https://doi.org/10.1097/ICU.0000000000000732
PubMed ID:33470670

Download

Full text not available from this repository.
View at publisher

Get full-text in a library